Literature DB >> 15684812

Comparison of topical steroids for acute anterior uveitis.

S S Samudre1, F A Lattanzio, P B Williams, J D Sheppard.   

Abstract

This study objectively compares efficacy of dexamethasone Na phosphate 0.1%, fluorometholone 0.1% (FML), loteprednol etabonate 0.5% (Lotemax [LE]; Bausch & Lomb Pharmaceuticals, Inc., Tampa, FL), prednisolone acetate 1% (Pred Forte [PRED F]; Allergan Pharmaceuticals, Irvine, CA), and generic prednisolone acetate 1% (PRED A). These steroids were administered for 24 hours or 72 hours to New Zealand white rabbits with endotoxin-induced uveitis. Intraocular pressure (IOP), slit-lamp examination, and confocal microscopy were performed daily. Internalization of the glucocorticoid receptor (GC) was assayed in iris tissue by Western blot, and protein in aqueous humor by Bradford assay. Only LE and PRED F treatments significantly internalized GC receptor after 72 hours of treatment. Only LE and PRED A reduced protein concentration between 24 hours and 72 hours of treatment. All drugs improved clinical signs after 24 hours of treatment. None of the steroids promoted return of the inflammation-induced corneal thickness to baseline. While none returned IOP to baseline, LE was most effective. Confocal microscopy indicated that only treatment with LE reverted the abnormal endothelial-cell shape to normal. In conclusion, all steroid treatments reduced uveitis to some degree but LE was consistently effective. A longer observation period may be required to document the return of IOP and corneal thickness to baseline values.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15684812     DOI: 10.1089/jop.2004.20.533

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  18 in total

1.  Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated.

Authors:  Sandeep Samudre; Frank A Lattanzio; Victoria Lossen; Alireza Hosseini; John D Sheppard; Robert L McKown; Gordon W Laurie; Patricia B Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-05       Impact factor: 4.799

Review 2.  Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.

Authors:  Rosa Bou; Alfredo Adán; Fátima Borrás; Beatriz Bravo; Inmaculada Calvo; Jaime De Inocencio; Jesús Díaz; Julia Escudero; Alex Fonollosa; Carmen García de Vicuña; Victoria Hernández; Rosa Merino; Jesús Peralta; María-Jesús Rúa; Pilar Tejada; Jordi Antón
Journal:  Rheumatol Int       Date:  2015-02-06       Impact factor: 2.631

3.  Inhibition of aldose reductase attenuates endotoxin signals in human non-pigmented ciliary epithelial cells.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Exp Eye Res       Date:  2010-02-04       Impact factor: 3.467

4.  Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

Authors:  Matt H Oltmanns; Sandeep S Samudre; Ivan G Castillo; Alireza Hosseini; Aron H Lichtman; Robert C Allen; Frank A Lattanzio; Patricia B Williams
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

5.  Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

6.  Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1.

Authors:  Umesh C S Yadav; Sumitra Subramanyam; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

7.  Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery.

Authors:  Timothy L Comstock; Michael R Paterno; Angele Singh; Tara Erb; Elizabeth Davis
Journal:  Clin Ophthalmol       Date:  2011-02-10

8.  Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery.

Authors:  Rahul Reddy; Stephen Jae Kim
Journal:  Clin Ophthalmol       Date:  2011-06-03

9.  A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.

Authors:  Xiaolu Yang; Huiyi Jin; Kun Liu; Qing Gu; Xun Xu
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Use of loteprednol for routine prophylaxis after photorefractive keratectomy.

Authors:  Mark D Mifflin; Lisa L Leishman; Steven M Christiansen; Shameema Sikder; Maylon Hsu; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.